r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

KP

Karah Herdman Parschauer

Insider · EVP and Chief Legal Officer · RARE

Karah Herdman Parschauer files insider transactions with the SEC as an evp and chief legal officer of Ultragenyx Pharmaceutical (RARE). We hold 5 disclosed purchases and sales filed since 22 June 2016, 2 of them in the last 90 days.

  • Files forRARE
  • Disclosed buys and sells5 in all, 2 in the last 90 days
  • Last disclosure4 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 June 2016 — 3 August 2026EVP and Chief Legal Officer · Ultragenyx Pharmaceutical (RARE)100 Form 4 lines · source: SEC Form 4
  • Filed 22 December 2021 — 28 May 2026Director · Tenaya Therapeutics (TNYA)6 Form 4 lines · source: SEC Form 4
  • Filed 15 July 2019 — 17 February 2026Director · Evolus (EOLS)15 Form 4 lines · source: SEC Form 4
  • Filed 21 April 2022 — 21 April 2022Director · Anebulo Pharmaceuticals (ANEB)1 Form 4 line · source: SEC Form 4
  • Filed 25 October 2019 — 18 June 2021Director · Arcturus Therapeutics Holdings (ARCT)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.